Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)
Top Cited Papers
- 1 July 2003
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 92 (2), 152-160
- https://doi.org/10.1016/s0002-9149(03)00530-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial diseaseThe American Journal of Cardiology, 2003
- Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: A randomized, double-blind, 52-week trialAmerican Heart Journal, 2002
- Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemiaAmerican Heart Journal, 2002
- Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemiaThe American Journal of Cardiology, 2002
- Rosuvastatin Demonstrates Greater Reduction of Low-Density Lipoprotein Cholesterol Compared with Pravastatin and Simvastatin in Hypercholesterolaemic Patients: A Randomized, Double-Blind StudyEuropean Journal of Preventive Cardiology, 2001
- A Comparison of Simvastatin and Atorvastatin up to Maximal Recommended Doses in a Large Multicenter Randomized Clinical TrialCurrent Medical Research and Opinion, 2001
- A Comparison of Simvastatin and Atorvastatin up to Maximal Recommended Doses in a Large Multicenter Randomized Clinical TrialCurrent Medical Research and Opinion, 2001
- Drug Treatment of Lipid DisordersNew England Journal of Medicine, 1999
- Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary PreventionEuropean Heart Journal, 1998
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.The American Journal of Cardiology, 1998